カテゴリー：世界, 医療/バイオ, IMARC

エピネフリン自己注射器のグローバル市場：0.15mg、0.3mg

【英語タイトル】Epinephrine Autoinjector Market by Dosage (0.15mg Epinephrine Autoinjector, 0.3mg Epinephrine Autoinjector, 0.5mg Epinephrine Autoinjector), Application (Under 6 Years, 6 to 12 Years, Over 12 Years), End User (Hospitals, Clinics, and Others), and Region 2023-2028
	・商品コード：IMARC23JLY174 ・発行会社（調査会社）：IMARC ・発行日：2023年7月・ページ数：146 ・レポート言語：英語・レポート形式：PDF ・納品方法：Eメール・調査対象地域：グローバル・産業分野：医療機器

◆販売価格オプション（消費税別）

Single User	USD2,999 ⇒換算￥455,848	見積依頼/購入/質問フォーム
Five User	USD3,999 ⇒換算￥607,848	見積依頼/購入/質問フォーム
Enterprisewide	USD4,999 ⇒換算￥759,848	見積依頼/購入/質問フォーム

※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）

❖ レポートの概要 ❖

IMARC社の調査資料によると、2022年22億ドルであった世界のエピネフリン自己注射器市場規模が、予測期間中（2023年～2028年）年平均9.4％成長し、2028年には34億ドルに達すると予測されています。当書は、エピネフリン自己注射器の世界市場を調査・分析し、序論、範囲・調査手法、エグゼクティブサマリー、イントロダクション、投与量別（0.15mg、0.3mg）分析、用途別（6歳以下、6～12歳、12際以上）分析、エンドユーザー別（病院、診療所、その他）分析、地域別（北米、アジア太平洋、ヨーロッパ、中南米、中東/アフリカ）分析、推進要因・阻害要因・機会、バリューチェーン分析、ファイブフォース分析、価格分析、競争状況などの項目がまとめられています。なお、当書に掲載されている企業情報には、Adamis Pharmaceuticals Corporation、Amneal Pharmaceuticals Inc.、Antares Pharma Inc、Bausch Health、Kaleo Inc.、Teva Pharmaceutical Industries Ltd.、Viatris Inc.などが含まれています。
・序論
・範囲・調査手法
・エグゼクティブサマリー
・イントロダクション
・世界のエピネフリン自己注射器市場規模：投与量別
- 0.15mgエピネフリン自己注射器の市場規模
- 0.3mgエピネフリン自己注射器の市場規模
・世界のエピネフリン自己注射器市場規模：用途別
- 6歳以下における市場規模
- 6～12歳における市場規模
- 12際以上における市場規模
・世界のエピネフリン自己注射器市場規模：エンドユーザー別
- 病院における市場規模
- 診療所における市場規模
- その他エンドユーザーにおける市場規模
・世界のエピネフリン自己注射器市場規模：地域別
- 北米のエピネフリン自己注射器市場規模
- アジア太平洋のエピネフリン自己注射器市場規模
- ヨーロッパのエピネフリン自己注射器市場規模
- 中南米のエピネフリン自己注射器市場規模
- 中東/アフリカのエピネフリン自己注射器市場規模
・推進要因・阻害要因・機会
・バリューチェーン分析
・ファイブフォース分析
・価格分析
・競争状況

Market Overview:

The global epinephrine autoinjector market size reached US$ 2.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.4 Billion by 2028, exhibiting a growth rate (CAGR) of 9.40% during 2023-2028. The increasing number of individuals with allergies, rising need for self-administrating medicines, and the launch of smart epinephrine autoinjector represent some of the key factors driving the market.

Epinephrine autoinjector is a medical device used to administer single dose epinephrine easily for treating severe allergic reactions caused by stings, bug bites, or drugs. It is designed to deliver the medication into the thigh muscle of an individual and works by constricting blood vessels and dilating the airways to minimize the symptoms of an allergic reaction. It is small and easy to carry and can be administered by individuals or healthcare professionals. At present, leading manufacturers are introducing epinephrine autoinjector with multiple doses of medications and adjustable dosages that enable the user to adjust the dose according to the severity of the allergic reaction and improve the effectiveness of the treatment. They are also incorporating audio and visual instructions to make it easier for individuals to use them in an emergency.

Epinephrine Autoinjector Market Trends:
The increasing number of individuals with allergies and allergic reactions and the rising need for self-administrating medicines represent one of the major factors driving the demand for epinephrine autoinjectors around the world. Moreover, the surging prevalence of arthritis, asthma, cancer, and chronic obstructive pulmonary disease (COPD) and the growing aging population, which is more prone to develop allergic reactions, is influencing the market positively. In addition, the increasing incidence of food allergies among the masses is bolstering the growth of the market. Apart from this, governing agencies of numerous countries are undertaking initiatives to promote the use of epinephrine autoinjectors in schools and other public spaces. This, coupled with the rising awareness about epinephrine autoinjectors, is contributing to the market growth. Furthermore, key players are introducing smart epinephrine autoinjectors that are integrated with advanced technologies, including Bluetooth connectivity, sensors, and machine learning, to make them more convenient, user friendly, and effective. Leading players are also launching mobile applications that can be connected to smartphones or other devices, allowing remote monitoring, tracking of usage and expiration dates, and ensuring the patient does not exceed the recommended dosage. These advancements can also help predict the likelihood of an allergic reaction and provide personalized recommendations for treatment. This, along with the incorporation of an automated external defibrillator (AED) in epinephrine autoinjectors to offer a comprehensive emergency response system, is creating a positive outlook for the market.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global epinephrine autoinjector market, along with forecasts at the global, regional, and country level from 2023-2028. Our report has categorized the market based on dosage, application, and end user.

Dosage Insights:
0.15mg Epinephrine Autoinjector
0.3mg Epinephrine Autoinjector
0.5mg Epinephrine Autoinjector

The report has provided a detailed breakup and analysis of the epinephrine autoinjector market based on the dosage. This includes 0.15mg epinephrine autoinjector, 0.3mg epinephrine autoinjector, and 0.5mg epinephrine autoinjector. According to the report, 0.3mg epinephrine autoinjector represented the largest segment.

Application Insights:
Under 6 Years
6 to 12 Years
Over 12 Years

A detailed breakup and analysis of the epinephrine autoinjector market based on the application has also been provided in the report. This includes under 6 years, 6 to 12 years, and over 12 years. According to the report, 6 to 12 years represented the largest segment.

End User Insights:
Hospitals
Clinics
Others

The report has provided a detailed breakup and analysis of the epinephrine autoinjector market based on the end user. This includes hospitals, clinics, and others. According to the report, hospitals represented the largest segment.

Regional Insights:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for epinephrine autoinjectors. Some of the factors driving the North America epinephrine autoinjector market included the rising prevalence of allergies, increasing awareness about anaphylaxis, and the availability of cost-effective generic versions of autoinjectors.

Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the global epinephrine autoinjector market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Adamis Pharmaceuticals Corporation, Amneal Pharmaceuticals Inc., Antares Pharma Inc, Bausch Health, Kaleo Inc., Teva Pharmaceutical Industries Ltd., Viatris Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:
How has the global epinephrine autoinjector market performed so far, and how will it perform in the coming years?
What are the drivers, restraints, and opportunities in the global epinephrine autoinjector market?
What is the impact of each driver, restraint, and opportunity on the global epinephrine autoinjector market?
What are the key regional markets?
Which countries represent the most attractive epinephrine autoinjector markets?
What is the breakup of the market based on the dosage?
Which is the most attractive dosage in the epinephrine autoinjector market?
What is the breakup of the market based on the application?
Which is the most attractive application in the epinephrine autoinjector market?
What is the breakup of the market based on the end user?
Which is the most attractive end user in the epinephrine autoinjector market?
What is the competitive structure of the global epinephrine autoinjector market?
Who are the key players/companies in the global epinephrine autoinjector market?

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Epinephrine Autoinjector Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Dosage
6.1 0.15mg Epinephrine Autoinjector
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 0.3mg Epinephrine Autoinjector
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 0.5mg Epinephrine Autoinjector
6.3.1 Market Trends
6.3.2 Market Forecast
7 Market Breakup by Application
7.1 Under 6 Years
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 6 to 12 Years
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Over 12 Years
7.3.1 Market Trends
7.3.2 Market Forecast
8 Market Breakup by End User
8.1 Hospitals
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Clinics
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Others
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 Drivers, Restraints, and Opportunities
10.1 Overview
10.2 Drivers
10.3 Restraints
10.4 Opportunities
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Adamis Pharmaceuticals Corporation
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.2 Amneal Pharmaceuticals Inc.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.3 Antares Pharma Inc
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 SWOT Analysis
14.3.4 Bausch Health
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 Kaleo Inc.
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.6 Teva Pharmaceutical Industries Ltd.
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 Viatris Inc.
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials

Figure 1: Global: Epinephrine Autoinjector Market: Major Drivers and Challenges
Figure 2: Global: Epinephrine Autoinjector Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Epinephrine Autoinjector Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Epinephrine Autoinjector Market: Breakup by Dosage (in %), 2022
Figure 5: Global: Epinephrine Autoinjector Market: Breakup by Application (in %), 2022
Figure 6: Global: Epinephrine Autoinjector Market: Breakup by End User (in %), 2022
Figure 7: Global: Epinephrine Autoinjector Market: Breakup by Region (in %), 2022
Figure 8: Global: Epinephrine Autoinjector (0.15mg Epinephrine Autoinjector) Market: Sales Value (in Million US$), 2017 & 2022
Figure 9: Global: Epinephrine Autoinjector (0.15mg Epinephrine Autoinjector) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 10: Global: Epinephrine Autoinjector (0.3mg Epinephrine Autoinjector) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: Epinephrine Autoinjector (0.3mg Epinephrine Autoinjector) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: Epinephrine Autoinjector (0.5mg Epinephrine Autoinjector) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Epinephrine Autoinjector (0.5mg Epinephrine Autoinjector) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Epinephrine Autoinjector (Under 6 Years) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Epinephrine Autoinjector (Under 6 Years) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Epinephrine Autoinjector (6 to 12 Years) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Epinephrine Autoinjector (6 to 12 Years) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: Epinephrine Autoinjector (Over 12 Years) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: Epinephrine Autoinjector (Over 12 Years) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Epinephrine Autoinjector (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Epinephrine Autoinjector (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Global: Epinephrine Autoinjector (Clinics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Global: Epinephrine Autoinjector (Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: Global: Epinephrine Autoinjector (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: Global: Epinephrine Autoinjector (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: North America: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: North America: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: United States: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: United States: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: Canada: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: Canada: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: Asia-Pacific: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: Asia-Pacific: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: China: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: China: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: Japan: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: Japan: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: India: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: India: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: South Korea: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: South Korea: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: Australia: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: Australia: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: Indonesia: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: Indonesia: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: Others: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: Others: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: Europe: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: Europe: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: Germany: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: Germany: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: France: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: France: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: United Kingdom: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: United Kingdom: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: Italy: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: Italy: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: Spain: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: Spain: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: Russia: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: Russia: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: Others: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: Others: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: Latin America: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: Latin America: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: Brazil: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: Brazil: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: Mexico: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: Mexico: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 70: Others: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
Figure 71: Others: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 72: Middle East and Africa: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
Figure 73: Middle East and Africa: Epinephrine Autoinjector Market: Breakup by Country (in %), 2022
Figure 74: Middle East and Africa: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 75: Global: Epinephrine Autoinjector Industry: Drivers, Restraints, and Opportunities
Figure 76: Global: Epinephrine Autoinjector Industry: Value Chain Analysis
Figure 77: Global: Epinephrine Autoinjector Industry: Porter's Five Forces Analysis

★調査レポート[エピネフリン自己注射器のグローバル市場：0.15mg、0.3mg] (コード：IMARC23JLY174)販売に関する免責事項を必ずご確認ください。

★調査レポート[エピネフリン自己注射器のグローバル市場：0.15mg、0.3mg]についてメールでお問い合わせ

MarketReport.jp

エピネフリン自己注射器のグローバル市場：0.15mg、0.3mg

市場調査レポート・産業資料総合販売サイト www.MarketReport.jp

市場調査レポート・産業資料 総合販売サイト www.MarketReport.jp

市場調査レポート・産業資料総合販売サイト www.MarketReport.jp